Zojwalla Naseem 4
4 · Olema Pharmaceuticals, Inc. · Filed Dec 7, 2023
Insider Transaction Report
Form 4
Zojwalla Naseem
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2023-12-06$7.02/sh+13,100$91,962→ 43,764 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-06−13,100→ 236,900 totalExercise: $7.02Exp: 2032-01-31→ Common Stock (13,100 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vested on January 31, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.